Showing results (81-90 of 116) with videos related to
Sort By:
Pageof 12
Alzheimer'S Research & Therapy|August 19, 2017
Distinct white matter microstructural abnormalities and extracellular water increases relate to cognitive impairment in Alzheimer's disease with and without cerebrovascular diseaseFang Ji, Ofer Pasternak, Siwei Liu, et al.Brain : a Journal of Neurology|October 21, 2017
Influence of cerebrovascular disease on brain networks in prodromal and clinical Alzheimer's diseaseJoanna Su Xian Chong, Siwei Liu, Yng Miin Loke, et al.Neuroscience Letters|December 3, 2014
Retinal neurodegeneration on optical coherence tomography and cerebral atrophyYi-Ting Ong, Saima Hilal, Carol Y Cheung, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 28, 2022
Subcortical brain structures and the risk of dementia in the Rotterdam StudyIsabelle F van der Velpen, Vanja Vlasov, Tavia E Evans, et al.Journal of Alzheimer'S Disease : JAD|April 16, 2016
Validation of the Total Cerebrovascular Disease Burden Scale in a Community SampleXin Xu, Saima Hilal, Simon L Collinson, et al.Scientific Reports|February 3, 2017
Retinopathy Signs Improved Prediction and Reclassification of Cardiovascular Disease Risk in Diabetes: A prospective cohort studyHenrietta Ho, Carol Y Cheung, Charumathi Sabanayagam, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 10, 2022
Genome-wide profiling of circulatory microRNAs associated with cognition and dementiaAmber Yaqub, Michelle M J Mens, Jaco M Klap, et al.Acta Ophthalmologica|June 5, 2014
Prevalence and risk factors for retinopathy in persons without diabetes: the Singapore Indian Eye StudyMayuri Bhargava, Carol Yim-lui Cheung, Charumathi Sabanayagam, et al.Iranian Journal of Pharmaceutical Research : IJPR|December 5, 2017
Fluoxetine Regulates Ig Kappa Chain C Region Expression Levels in the Serum of Obsessive-Compulsive Disorder Patients: A proteomic ApproachMona Zamanian Azodi, Mostafa Rezaei Tavirani, Afsaneh Arefi Oskouie, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 22, 2007
A placebo controlled study of the propentofylline added to risperidone in chronic schizophreniaSamarand Salimi, Akbar Fotouhi, Abolfazl Ghoreishi, et al.Pageof 12